David Barrett - Assembly Biosciences Insider

ASMB -- USA Stock  

USD 46.17  1.87  3.89%

CFO, COO

Mr. David J. Barrett CPA, is Chief Financial Officer, Chief Operating Officer of Company. From April 2006 to September 2009, Mr. Barrett served as Chief Financial Officer of NeuroHitech, Inc., a public company focused on developing, marketing and distributing branded and generic pharmaceutical products. From September 2003 to April 2006, Mr. Barrett was the Chief Financial OfficerVice President of Finance of Overture Asset Managers and Overture Financial Services, which, at the time, was a startup asset management firm that assembled investment products and platforms to distribute turnkey and unbundled investment solutions to financial intermediaries and institutional investors. From July 1999 to September 2003, Mr. Barrett was employed as a Manager at Deloitte Touche, LLP. Mr. Barrett also is a director of Coronado Biosciences, Inc., a biopharmaceutical Company
Age: 38  COO Since 2015      
317-210-9311  http://www.assemblybio.com
Barrett received his B.S. in Accounting and Economics and his M.S. in Accounting from the University of Florida. He is a certified public accountant.

David Barrett Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (23.67) % which means that it has lost $23.67 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (53.01) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 2 records

COO Since

Alexander SchuthDenali Therapeutics
N/A
Daniel OrlandoVericel Corporation
2013

Entity Summary

Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana. Assembly Biosciences operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 85 people.Assembly Biosciences (ASMB) is traded on Nasdaq Capital Markets in USA. It is located in NEW YORK, U.S.A and employs 85 people. Assembly Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.

Assembly Biosciences Leadership Team

Uri Lopatin, President, Ph.D
Helen Kim, Director, MBA
Myron Holubiak, Director
Lee Arnold, Executive, Ph.D
Anthony Altig, Director
Richard Colonno, Executive
Graham Cooper, COO, MBA
William Ringo, Chairman, MBA
Susan Mahony, Director
Richard DiMarchi, Director, Ph.D
Miguel Barbosa, Executive, Ph.D
Thomas Rollins, Executive
Mark Auerbach, Director
Derek Small, CEO
Alan Lewis, Director, Ph.D
David Barrett, COO

Stock Performance Indicators

Current Sentiment - ASMB

Assembly Biosciences Investor Sentiment
Most of Macroaxis users are presently bullish on Assembly Biosciences. What is your sentiment towards investing in Assembly Biosciences? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Assembly Biosciences and NantKwest. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.